aspirin_TS_487964117 A population-based study found no effect of low-dose aspirin use within 1 year of diagnosis on prostate cancer death risk. Use of low-dose aspirin after a diagnosis of prostate ...
Whole blood androgen receptor (AR) variant (ARV12, ARV14) expression and overall survival (OS) in metastatic castrate resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2017 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results